News from Zyme and the companies we work with.
SPT Labtech and Semarion Collaborate to Advance Automated Cell-Based Assay Workflows
Integration of firefly® liquid handling platform and SemaCyte® microcarriers enables flexible, miniaturized, and automated cell assay workflows Cambridge, UK, 9th July 2025: SPT Labtech, a global leader in innovative laboratory [...]
Centauri Therapeutics appoints Dr. Debra Barker as Chief Medical Officer
Experienced clinical immunologist and global life science executive to support progression of lead candidate through the clinic ABX-01 clinical candidate is an immunotherapeutic, based on proprietary Alphamer® platform and designed [...]
Optibrium secures multi-million-pound financing package from Shawbrook to accelerate business growth
Proceeds will accelerate Optibrium’s product development and expand the global reach of its computational chemistry and AI-driven discovery technology CAMBRIDGE, UK, 08 July 2025 – Optibrium, a leading developer of software [...]
SolasCure publishes Dose Escalation Study on painless application of Aurase Wound Gel
Peer-reviewed study in the International Wound Journal compares pain levels of enzymatic debridement against current methods Study results indicate that Aurase Wound Gel can achieve debridement without any additional pain [...]
Bio-Rad Expands Droplet Digital PCR Offering Through Strategic Acquisition and Platform Rollout
HERCULES, Calif. — July 7, 2025 — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of [...]
Optibrium Partners with TalTech on EU-Funded PhD Programme to Advance Sustainable Drug Discovery
The research will focus on developing faster and more accurate methods for predicting drug metabolism CAMBRIDGE, UK, 02 July 2025 – Optibrium, a leading developer of software and AI solutions [...]
Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery
Study identifies new metrics to enhance scRNA-seq based virtual cell modelling Foundational paper to drive development of improved virtual cell models for rejuvenation target discovery Cambridge, UK, 1 July 2025: [...]
4basebio Introduces New Branding to Reflect Next Phase of Growth Enabling Development of Advanced Genetic Therapies
Expanding capabilities in delivering scalable, high-quality synthetic DNA solutions to the global market Cambridge, UK, 01 July 2025 – 4basebio PLC (AIM: 4BB) (“4basebio”), a specialist in synthetic DNA manufacturing [...]
Zyme Communications celebrates 15 years of providing specialist support for the life science sector
Cambridge and Manchester, UK, 25 June 2025: Zyme Communications Ltd. (Zyme), the life science specialist PR and marketing agency, today celebrates its 15-year anniversary, and introduces refreshed branding to reflect [...]
Enhanced Genomics and The ALBORADA Drug Discovery Institute partner to accelerate Alzheimer’s drug discovery
Enhanced Genomics’ 3D multi-omics platform harnessed to rapidly identify multiple novel therapeutic targets that were undetectable using conventional genomic approaches Breakthrough demonstrates the potential of 3D multi-omics to revolutionize drug [...]
OutSee raises £1.8M seed funding to expand therapeutic pipeline using predictive genomics
Financing led by Ahren Innovation Capital with additional investment from Kadmos Capital, Empirical Ventures and Panacea Ventures Investment to leverage OutSee’s proprietary AI-based predictive genomics technology, Nomaly, to expand and [...]
Bio-Rad Extends Anti-Idiotypic Antibody and SpyCatcher Reagent Ranges for Bioanalysis and Antibody Drug Development
Additions to Company’s Range of Bioanalytical Antibodies and Reagents Enhances Bioanalysis and Antibody-Related Research HERCULES, Calif. — June 17, 2025 — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global [...]
